NYSE:CSLT

Stock Analysis Report

Executive Summary

Castlight Health, Inc. provides a software-as-a-service platform used for health benefits navigation for employees in the United States.

Snowflake

Fundamentals

Adequate balance sheet and fair value.


Similar Companies

Share Price & News

How has Castlight Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.7%

CSLT

-2.1%

US Healthcare Services

0.07%

US Market


1 Year Return

-33.3%

CSLT

18.1%

US Healthcare Services

8.9%

US Market

Return vs Industry: CSLT underperformed the US Healthcare Services industry which returned 18.1% over the past year.

Return vs Market: CSLT underperformed the US Market which returned 8.9% over the past year.


Shareholder returns

CSLTIndustryMarket
7 Day2.7%-2.1%0.07%
30 Day-5.1%-5.4%-0.3%
90 Day-46.8%-10.1%-1.6%
1 Year-33.3%-33.3%18.3%18.1%11.3%8.9%
3 Year-67.0%-67.0%65.0%64.5%46.3%36.8%
5 Year-88.3%-88.3%60.9%59.6%62.1%44.3%

Price Volatility Vs. Market

How volatile is Castlight Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Castlight Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CSLT ($1.5) is trading below our estimate of fair value ($3.42)

Significantly Below Fair Value: CSLT is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CSLT is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.

PE vs Market: CSLT is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CSLT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CSLT is good value based on its PB Ratio (1.2x) compared to the US Healthcare Services industry average (3.5x).


Next Steps

Future Growth

How is Castlight Health forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

33.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CSLT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CSLT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CSLT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CSLT's revenue (9.7% per year) is forecast to grow faster than the US market (7.2% per year).

High Growth Revenue: CSLT's revenue (9.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CSLT's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Castlight Health performed over the past 5 years?

18.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: CSLT is unprofitable, but has reduced losses over the past 5 years at a rate of 18.1% per year.

Accelerating Growth: Unable to compare CSLT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CSLT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-5.7%).


Return on Equity

High ROE: CSLT has a negative Return on Equity (-16.21%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: CSLT is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: CSLT is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Castlight Health's financial position?


Financial Position Analysis

Short Term Liabilities: CSLT's short term assets ($102.0M) exceeds its short term liabilities ($54.3M)

Long Term Liabilities: CSLT's short term assets (102.0M) exceeds its long term liabilities (16.3M)


Debt to Equity History and Analysis

Debt Level: CSLT's debt to equity ratio (2.2%) is considered satisfactory

Reducing Debt: Insufficient data to determine if CSLT's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: CSLT has a low level of unsold assets or inventory.

Debt Coverage by Assets: CSLT's debt is covered by short term assets (assets are 24.381300x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CSLT has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CSLT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Castlight Health's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.0%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate CSLT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CSLT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if CSLT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CSLT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CSLT's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Castlight Health's salary, the management and board of directors tenure and is there insider trading?

3.2yrs

Average management tenure


CEO

Maeve O'Meara 0

0.3yrs

Tenure

US$2,997,799

Compensation

Ms. Maeve O'Meara is the Chief Executive Officer and Director of Castlight Health, Inc. since July 2019. She served as an Executive Vice President of Product and Customer Experience at Castlight Health, In ...


CEO Compensation Analysis

Compensation vs. Market: Maeve has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Maeve's compensation with company performance.


Management Age and Tenure

3.2yrs

Average Tenure

49yo

Average Age

Experienced Management: CSLT's management team is considered experienced (3.2 years average tenure).


Board Age and Tenure

3.2yrs

Average Tenure

51yo

Average Age

Experienced Board: CSLT's board of directors are considered experienced (3.2 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellUS$64,72003 Jul 19
Maeve O'Meara
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares20,835
Max PriceUS$3.11
SellUS$31,86122 Feb 19
Maeve O'Meara
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares9,937
Max PriceUS$3.21
SellUS$33,84122 Feb 19
Neeraj Gupta
EntityIndividual
Role
Senior Key Executive
Senior Vice President of Engineering
Shares10,550
Max PriceUS$3.21
SellUS$38,96820 Nov 18
Maeve O'Meara
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares14,236
Max PriceUS$2.74
SellUS$2,70820 Nov 18
Neeraj Gupta
EntityIndividual
Role
Senior Key Executive
Senior Vice President of Engineering
Shares1,045
Max PriceUS$2.59
SellUS$36,64820 Nov 18
Siobhan Mangini
EntityIndividual
Role
President
President & CFO
Shares13,997
Max PriceUS$2.62
SellUS$49,86620 Nov 18
John Doyle
EntityIndividual
Shares18,519
Max PriceUS$2.69
SellUS$19,54120 Nov 18
M P Chan
EntityIndividual
Role
Chief Accounting Officer
Chief Accounting Officer
Shares7,406
Max PriceUS$2.64

Ownership Breakdown


Management Team

  • Bryan Roberts (52yo)

    Chairman of the Board & Co-Founder

    • Tenure: 2yrs
    • Compensation: US$212.50k
  • Maeve O'Meara

    CEO & Director

    • Tenure: 0.3yrs
    • Compensation: US$3.00m
  • John McCracken (52yo)

    Chief Revenue Officer

    • Tenure: 3.3yrs
    • Compensation: US$3.09m
  • Gary Fuges

    Head of Investor Relations

    • Tenure: 0yrs
  • Vicki Ryan

    Chief People Officer

    • Tenure: 0yrs
  • Neeraj Gupta (47yo)

    Senior Vice President of Engineering

    • Tenure: 3.2yrs
    • Compensation: US$1.75m
  • Jennifer Chaloemtiarana (51yo)

    Chief Compliance Officer

    • Tenure: 4.9yrs
    • Compensation: US$1.64m
  • Siobhan Mangini (38yo)

    President & CFO

    • Tenure: 0.3yrs
    • Compensation: US$1.13m
  • M P Chan (43yo)

    Chief Accounting Officer

    • Tenure: 2.2yrs

Board Members

  • Bryan Roberts (52yo)

    Chairman of the Board & Co-Founder

    • Tenure: 2yrs
    • Compensation: US$212.50k
  • David Ebersman (50yo)

    Independent Director

    • Tenure: 8.3yrs
    • Compensation: US$180.00k
  • David Singer (56yo)

    Independent Director

    • Tenure: 9.3yrs
    • Compensation: US$182.03k
  • Kenny Van Zant (49yo)

    Director

    • Tenure: 3.2yrs
    • Compensation: US$175.00k
  • Mike Eberhard (53yo)

    Director

    • Tenure: 3.3yrs
    • Compensation: US$185.35k
  • Ed Park (44yo)

    Independent Director

    • Tenure: 5.5yrs
    • Compensation: US$196.85k
  • Maeve O'Meara

    CEO & Director

    • Tenure: 0.3yrs
    • Compensation: US$3.00m
  • Judy Verhave (62yo)

    Director

    • Tenure: 1.3yrs
    • Compensation: US$232.30k
  • Seth Cohen (38yo)

    Director

    • Tenure: 1.8yrs
    • Compensation: US$382.08k

Company Information

Castlight Health, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Castlight Health, Inc.
  • Ticker: CSLT
  • Exchange: NYSE
  • Founded: 2008
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$217.876m
  • Shares outstanding: 145.25m
  • Website: https://www.castlighthealth.com

Number of Employees


Location

  • Castlight Health, Inc.
  • 150 Spear Street
  • Suite 400
  • San Francisco
  • California
  • 94105
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CSLTNYSE (New York Stock Exchange)YesClass B Common StockUSUSDMar 2014
109DB (Deutsche Boerse AG)YesClass B Common StockDEEURMar 2014

Biography

Castlight Health, Inc. provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 00:25
End of Day Share Price2019/10/22 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.